Evidence map›Paper›PMID 15042275›Full record

ArticlePsychopharmacology2004

Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats.

John R Mantsch, Vadim Yuferov, Anne-Marie Mathieu-Kia, Ann Ho, Mary Jeanne Kreek

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed.

  1. Article
  2. Article
  3. Similarities and Differences in Diagnostic Criteria.Advances in experimental medicine and biology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Voltage-gated potassium channels control extended access cocaine seeking: a role for nucleus accumbens astrocytes.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  8. Altered neuronal activity in the ventromedial prefrontal cortex drives nicotine intake escalation.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  9. PPL-103: A mixed opioid partial agonist with desirable anti-cocaine properties.Progress in neuro-psychopharmacology & biological psychiatry · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Animal Models of the Behavioral Symptoms of Substance Use Disorders.Cold Spring Harbor perspectives in medicine · 2021
    Review
  16. Article
  17. An optimized procedure for robust volitional cocaine intake in mice.Experimental and clinical psychopharmacology · 2021
    Article
  18. Review
  19. Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

John R MantschThe Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY, USA. john.mantsch@marquette.edu
Vadim Yuferov
Anne-Marie Mathieu-Kia
Ann Ho
Mary Jeanne Kreek

Funding

UNIQUE RNA STRUCTURE OF CAUSATIVE AGENT FOR DELTA HEPATITISP50DA005130 · NIDA · ROCKEFELLER UNIVERSITY · PI KREEK, MARY J · 1987 to 2001
$5.0M
Addictive Drugs-Pharmacology &PhysiologyK05DA000049 · NIDA · ROCKEFELLER UNIVERSITY · PI KREEK, MARY J · 1985 to 2007
$1.0M
NIDA NIH HHS DA-K05-00049NIDA NIH HHS DA-P50-05130
6 · The paper itself

Abstract

rationaleThe investigation of rodent cocaine self-administration (SA) under conditions that promote escalating patterns of intake may provide insight into the loss of control over drug use that is central to human addiction.

objectiveThis study examines the effects of daily long-access (LgA) SA of high or low cocaine doses on drug intake, extinction, reinstatement, and brain mRNA levels.

methodsThree groups of male Sprague-Dawley rats were trained to self-administer cocaine during multiple-dose sessions. Short-access (ShA) rats were tested daily for multi-dose SA then remained in the chambers for 7 h with no cocaine available. LgA rats had access to low (0.5 mg/kg per infusion; LgA-LD) or high (2.0 mg/kg per infusion; LgA-HD) cocaine doses for 7 h after multi-dose SA. After 14 days, responding was extinguished, cocaine-induced reinstatement was determined, and preproenkephalin (ppENK), preprodynorphin (ppDYN), corticotropin releasing factor (CRF) and dopamine D(2) receptor (D(2)R) mRNA levels were measured in various brain regions using a quantitative solution hybridization RNase protection assay.

resultsWhereas SA was not altered in ShA rats and only increased during the "loading phase" in LgA-LD rats, a general escalation of intake was found in LgA-HD rats. LgA, particularly LgA-HD, rats were more susceptible to reinstatement than ShA rats. Caudate-putamen ppENK and nucleus accumbens D(2)R mRNA levels were elevated in LgA-HD rats. Overall, D(2)R mRNA levels were positively correlated with reinstatement.

conclusionsThe escalation of cocaine SA under LgA conditions is dose-dependent and is associated with heightened susceptibility to drug-induced relapse. The characterization of neurobiological alterations that accompany escalated SA should facilitate the identification of mechanisms underlying the onset of human addiction.

Indexed as

AnimalsBehavior, AddictiveBrainCocaineCocaine-Related DisordersCorticotropin-Releasing HormoneDose-Response Relationship, DrugDynorphinsEnkephalinsExtinction, PsychologicalMaleOpioid PeptidesProtein PrecursorsRatsRats, Sprague-DawleyReceptors, Dopamine D2CocaineCorticotropin-Releasing HormoneDynorphinsEnkephalinsOpioid Peptidespre-prodynorphinpreproenkephalinProtein PrecursorsReceptors, Dopamine D2RNA, Messenger

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.